Ravi Devambatla | Principal Research Scientist

1 min read 05th May 2026

Share via email Share via LinkedIn

Ravi Devambatla - Principal Research Scientist

Ravi Devambatla PhD, MS, BS

Principal Research Scientist

With over 15 years of experience in pharmaceutical manufacturing, Ravi joined our North Carolina site in August 2025 and now works as a Principal Research Scientist.

Education

Duquesne University, 2014, PhD, Medicinal Chemistry
Birla Institute of Technology and Science, 2007, BS and MS, Pharmacy, Medicinal Chemistry, Medicinal and Pharmaceutical Chemistry

Publications

Synthesis and characterization of an orally bioavailable small molecule agonist of the apelin receptor June 2022

Bioorganic and Medicinal Chemistry
Pyrazole Agonist of the Apelin Receptor Improves Symptoms of Metabolic Syndrome in Mice March 2021

Journal of Medicinal Chemistry

Sterling Resources

Building quality by design: How CPP and PAR studies ensure safe and scalable API manufacturing May 2026

Hex

Share via email Share via LinkedIn

Popular articles

Building quality by design: How CPP and PAR studies ensure safe and scalable API manufacturing

Whitepaper5 min read

Building quality by design: How CPP and PAR studies ensure safe and scalable API manufacturing Read more

Whitepaper7 min read

Scaling ring-closing metathesis in API development: Challenges and success factors Read more

ADC manufacturing facilities at Sterling Pharma Solutions' Deeside, Wales facilities

Blog7 min read

Top 5 considerations in ADC clinical manufacturing Read more

One pager5 min read

HPAPI development and manufacture: From medicinal chemistry to process chemistry Read more

Scott Bruce - Head of Production

Spotlight5 min read

Scientist Snapshot | Scott Bruce, Head of Production Read more

Infographic1 min read

Solid form development: Evaluating salt hits against free API to achieve an optimal target form Read more

Sign up for updates

Be the first to see the latest articles and updates from industry leaders, delivered straight to your inbox

Name

This field is for validation purposes and should be left unchanged.

Name(Required)

Email(Required)

Company Name(Required)

This field is hidden when viewing the form

Prospect Source

Please click here for our privacy policy

Service. Passion. Science.

PDMO^® is registered in the U.S. Patent and Trademark Office.

PDMO^® is a registered trademark of Sterling Pharma Solutions Limited (EUIPO and UKIPO). All rights reserved.

Sterling Pharma Solutions Limited. Registration number: 05712796. Registered office address: Dudley Lane, Dudley, Cramlington, NE23 7QG, United Kingdom. Registered in England.
VAT number: GB320549229